Cargando…

Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States

Detalles Bibliográficos
Autores principales:	Winston, Carla A., Mitruka, Kiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376819/ https://www.ncbi.nlm.nih.gov/pubmed/22709909 http://dx.doi.org/10.3201/eid1807.120261

Ejemplares similares

Tuberculosis Outbreak Investigations in the United States, 2002–2008
por: Mitruka, Kiren, et al.
Publicado: (2011)

Characteristics of Tuberculosis Cases that Started Outbreaks in the United States, 2002–2011
por: Haddad, Maryam B., et al.
Publicado: (2015)

Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States
por: Haley, Connie A., et al.
Publicado: (2021)

Unexpected decline in tuberculosis cases coincident with economic recession -- United States, 2009
por: Winston, Carla A, et al.
Publicado: (2011)

Clinical practice of chest physicians for treatment of drug-resistant tuberculosis
por: De, Sajal
Publicado: (2012)

Drug-Resistant Mycobacterium tuberculosis among New Tuberculosis Patients, Yangon, Myanmar
por: Phyu, Sabai, et al.
Publicado: (2003)

COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho
por: Andom, Afom T., et al.
Publicado: (2023)

Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Patients with Pulmonary Tuberculosis in Zahedan, Southeastern Iran
por: Metanat, M, et al.
Publicado: (2012)

Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis
por: Deoghare, Shashank
Publicado: (2013)

Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020)

Extensively Drug-Resistant Tuberculosis, China
por: Tang, Shenjie, et al.
Publicado: (2011)

Extensively Drug-Resistant Tuberculosis,Taiwan
por: Yu, Ming-Chih, et al.
Publicado: (2008)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

Spread of Extensively Drug-resistant Tuberculosis
por: Samper, Sofía, et al.
Publicado: (2007)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

Peritoneal Tuberculosis in a Pregnant Woman from Haiti, United States
por: Ard, Kevin L., et al.
Publicado: (2013)

Drug Resistant Tuberculosis in Adults and Its Treatment CME Infectious Diseases – II
por: Ormerod, L P
Publicado: (1998)

Extensively Drug-Resistant Mycobacterium tuberculosis, India
por: Mondal, Rajesh, et al.
Publicado: (2007)

Extensively Drug-resistant Tuberculosis, Italy and Germany
por: Migliori, Giovanni Battista, et al.
Publicado: (2007)

Cruise Ship Travel
por: Mitruka, Kiren, et al.
Publicado: (2008)

Primary Multidrug-Resistant Leprosy, United States
por: Williams, Diana Lynn, et al.
Publicado: (2013)

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline
por: Putra, Oki Nugraha, et al.
Publicado: (2021)

Beijing genotype of Mycobacterium tuberculosis is associated with extensively drug-resistant tuberculosis: A global analysis
por: Keikha, M., et al.
Publicado: (2021)

Ethics, human rights and programmatic management of drug-resistant tuberculosis
por: Dholakia, Yatin N.
Publicado: (2012)

Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009
por: Shi, Dawei, et al.
Publicado: (2012)

RE: “Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup”
por: Houben, R. M. G. J., et al.
Publicado: (2014)

Drug-resistant tuberculosis: Response to More et al. (2017)
por: Basu, Saurav
Publicado: (2017)

Living and dying with drug resistant tuberculosis - Are we doing enough?
por: Mehta, Vibha, et al.
Publicado: (2020)

Comparing cancer drug approval systems in the United States and Japan
por: Kaneda, Yudai, et al.
Publicado: (2023)

Estimating Ebola Treatment Needs, United States
por: Rainisch, Gabriel, et al.
Publicado: (2015)

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
por: Winston, Carla A., et al.
Publicado: (2023)

Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016
por: Bharat, Amrita, et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply
por: Kang, Yewon, et al.
Publicado: (2022)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
por: Pérez-Lago, Laura, et al.
Publicado: (2015)

Primary Multi Drug Resistant Extra-pulmonary Tuberculosis Presenting as Cervical Lymphadenitis
por: Datta, Saikat, et al.
Publicado: (2014)

Initial Costs of Ebola Treatment Centers in the United States
por: Herstein, Jocelyn J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_94lli9gp4lpn4b6t4d81evjqrl